Page last updated: 2024-09-03
n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and cholecalciferol
n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine has been researched along with cholecalciferol in 1 studies
Compound Research Comparison
Studies (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Trials (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Recent Studies (post-2010) (n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine) | Studies (cholecalciferol) | Trials (cholecalciferol) | Recent Studies (post-2010) (cholecalciferol) |
---|---|---|---|---|---|
78 | 0 | 12 | 8,234 | 1,425 | 3,471 |
Protein Interaction Comparison
Protein | Taxonomy | n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine (IC50) | cholecalciferol (IC50) |
---|---|---|---|
Vitamin D3 receptor | Homo sapiens (human) | 0.087 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Gadina, M; Tao-Cheng, JH; Wu, YN; Youle, RJ | 1 |
Other Studies
1 other study(ies) available for n-(7-(4-nitrobenzo-2-oxa-1,3-diazole))-6-aminocaproyl sphingosine and cholecalciferol
Article | Year |
---|---|
Retinoic acid disrupts the Golgi apparatus and increases the cytosolic routing of specific protein toxins.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Antibodies, Monoclonal; Biological Transport; Brefeldin A; Cell Line; Ceramides; Cholecalciferol; Cyclopentanes; Cytosol; Fluorescent Dyes; Gene Expression Regulation; Golgi Apparatus; Humans; Immunotoxins; Mannosidases; Rats; Receptors, Retinoic Acid; Ricin; Tretinoin; Triiodothyronine; Tumor Cells, Cultured | 1994 |